BioXcel Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Rolling Year Two
BioXcel Therapeutics, Inc. (BTAI) had Operating Leases, Future Minimum Payments, Due in Rolling Year Two of $192.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo · last filed 2019-03-12
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Rolling Year Two $192.00K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Rolling Year Two $192.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling Year Two |
|---|---|
| 2018-12-31 | $192.00K 10-K · filed 2019-03-12 |
| 2018-09-30 | $192.00K 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |